Barr Pharmaceuticals Company Description
Barr Pharmaceuticals is raising the bar and lowering the prices for many medications. The company is one of the world's largest makers of generic drugs, the cheaper knock-offs of off-patent branded pharmaceuticals. Through its Barr Laboratories subsidiary, the firm makes more than 120 generics for the North American market, with an emphasis on oral contraceptives. Barr's PLIVA subsidiary makes and sells more than 1,000 generic drugs, as well as pharmaceutical ingredients, primarily in Germany and Eastern Europe. The company also develops branded drugs through its Duramed unit, including contraceptives such as Seasonique and Plan B. Barr Pharmaceuticals was acquired by rival Teva Pharmaceutical in late 2008.
View the Comprehensive Company Description for Barr Pharmaceuticals
The Company Description provides a historical perspective of Barr Pharmaceuticals's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Barr Pharmaceuticals's evolution in the marketplace.
